Rapid Nutrition PLC (ALRPD.PA)
EUR 0.01
(-5.08%)
EUR 0.01
(-5.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.65 Million AUD | -43.31% |
| 2022 | 2.92 Million AUD | 4.68% |
| 2021 | 2.78 Million AUD | 13.71% |
| 2020 | 2.45 Million AUD | 0.0% |
| 2018 | 3.1 Million AUD | -27.0% |
| 2017 | 4.25 Million GBP | 30.82% |
| 2016 | 3.25 Million GBP | -20.69% |
| 2015 | 4.09 Million GBP | -27.18% |
| 2014 | 5.62 Million GBP | 252.84% |
| 2013 | 1.59 Million GBP | 403.93% |
| 2012 | 316.59 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 325.45 Thousand AUD | 0.0% |
| 2023 Q4 | 502.19 Thousand AUD | 0.0% |
| 2023 Q1 | 325.45 Thousand AUD | -32.49% |
| 2023 FY | 1.65 Million AUD | -43.31% |
| 2023 Q3 | 502.19 Thousand AUD | 54.31% |
| 2022 Q1 | 180.24 Thousand AUD | -77.41% |
| 2022 Q4 | 482.09 Thousand AUD | 0.0% |
| 2022 Q3 | 482.09 Thousand AUD | 167.47% |
| 2022 Q2 | 180.24 Thousand AUD | -0.0% |
| 2022 FY | 2.92 Million AUD | 4.68% |
| 2021 Q1 | 702.87 Thousand AUD | 0.0% |
| 2021 Q3 | 798 Thousand AUD | 13.54% |
| 2021 Q4 | 798 Thousand AUD | 0.0% |
| 2021 Q2 | 702.87 Thousand AUD | 0.0% |
| 2021 FY | 2.78 Million AUD | 13.71% |
| 2020 FY | 2.45 Million AUD | 0.0% |
| 2019 Q4 | 890 Thousand AUD | 0.0% |
| 2019 Q2 | 1.16 Million AUD | 0.0% |
| 2019 Q1 | 1.16 Million AUD | 197.89% |
| 2019 Q3 | 890 Thousand AUD | -23.43% |
| 2018 Q4 | 390.16 Thousand AUD | -0.0% |
| 2018 Q3 | 390.17 Thousand AUD | -36.61% |
| 2018 FY | 3.1 Million AUD | -27.0% |
| 2018 Q2 | 615.55 Thousand AUD | -17.81% |
| 2018 Q1 | 748.95 Thousand AUD | -44.84% |
| 2017 Q1 | 538.65 Thousand AUD | -47.99% |
| 2017 Q3 | 1.34 Million AUD | 140.85% |
| 2017 Q4 | 1.35 Million AUD | 1.27% |
| 2017 Q2 | 556.64 Thousand AUD | 3.34% |
| 2017 FY | 4.25 Million GBP | 30.82% |
| 2016 Q1 | 593.54 Thousand AUD | -36.66% |
| 2016 Q3 | 1.03 Million AUD | 377.76% |
| 2016 Q4 | 1.03 Million AUD | 0.0% |
| 2016 Q2 | 216.77 Thousand AUD | -63.48% |
| 2016 FY | 3.25 Million GBP | -20.69% |
| 2015 FY | 4.09 Million GBP | -27.18% |
| 2015 Q4 | 937.04 Thousand AUD | 0.0% |
| 2015 Q3 | 937.04 Thousand AUD | -47.44% |
| 2015 Q2 | 1.78 Million AUD | 0.0% |
| 2015 Q1 | 1.78 Million AUD | 72.73% |
| 2014 Q3 | 1.03 Million AUD | 2906.76% |
| 2014 FY | 5.62 Million GBP | 252.84% |
| 2014 Q4 | 1.03 Million AUD | 0.0% |
| 2014 Q2 | 34.32 Thousand AUD | 0.0% |
| 2013 Q2 | -157.74 Thousand AUD | 0.0% |
| 2013 FY | 1.59 Million GBP | 403.93% |
| 2012 FY | 316.59 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AB Science S.A. | 970 Thousand EUR | -70.648% |
| Boiron SA | 493.24 Million EUR | 99.664% |
| Ipsen S.A. | 3.3 Billion EUR | 99.95% |
| Malin Corporation plc | - EUR | -Infinity% |
| Vetoquinol SA | 529.27 Million EUR | 99.687% |